Hepatitis C virus infection in maintenance hemodialysis patients: recommendations for diagnostics and treatment
Int J Artif Organs 2016; 39(12): 590 - 595
Article Type: REVIEW
AuthorsPavlina Dzekova-Vidimliski, Aleksandar Sikole
Hepatitis C virus (HCV) infection is highly prevalent among patients treated with maintenance hemodialysis and is an important cause of morbidity and mortality. It is necessary to determine the HCV genotype and the viral load to monitor the clinical and laboratory features and to establish an optimal antiviral treatment strategy. Antiviral treatments are presented with a standard interferon-based regimen and new direct-acting antiviral agents. The advent of direct-acting antivirals has improved the efficacy and safety of HCV treatment for most patients, even in difficult-to-treat populations such as patients on hemodialysis. HCV treatment with direct-acting antivirals in hemodialysis patients is highly effective, with viral eradication rates similar to those seen in patients without chronic kidney disease and with acceptable adverse event profiles.
- • Accepted on 31/12/2016
- • Available online on 01/02/2017
- • Published in print on 10/02/2017